Viewing Study NCT03043950

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:17 PM
Ignite Modification Date: 2026-02-20 @ 12:41 PM
Study NCT ID: NCT03043950
Status: COMPLETED
Last Update Posted: 2024-04-24
First Post: 2017-02-02
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Validation of a New Prognostic Score for Adult Patients With RAS Wild-type mCRC Treated With Vectibix® and FOLFIRI or FOLFOX in First Line (VALIDATE)
Sponsor: iOMEDICO AG
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Colorectal Cancer View
None RAS Wild-type View
Keywords:

Keywords

Keyword Brief Keyword Text View
None mCRC View
None First line View
None Panitumumab View
None mCCS Prognostic Score View
None Prognosis View
None Ras wild type View